The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.

Arthritis Res Ther · 2011 · PMC3308109 · PMID 22024532

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients who were using other biologics (HR, 0.52; 95% CI, 0.19 to 1.40) or high-dose oral glucocorticoids (HR, 0.46; 95% CI, 0.15 to 1.45) were only half as likely as were non-users to receive zoster vaccine, but these associations did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.